THE ART AND SCIENCE OF MAKING MEDICINES
At Ironwood, we seek to transform knowledge into medicines that make a difference for patients. If we do this well, we will earn the right to do it again. We hope to inspire the continued support of our shareholders so we can serve patients. And over time, we will build an enduring pharmaceutical company that helps people lead better lives.
 
 
  RECENT NEWS
06.13.13
Constella (linaclotide), the first approved prescription therapy in a new class of treatments for adults with IBS-C, is now available in Europe
 
06.04.13
Ironwood Announces Partial Exercise of Underwriters' Option in Public Offering of Common Stock
 
    GROW WITH US
At Ironwood, we are all owners and founders.
 
Joining our team means pursuing excellence in yourself, in your colleagues, and in the company we're building together.
 
Find out more
   
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.